These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33426833)

  • 1. Critical Reviews on Pediatric Dosage Form Developments and Medical Devices.
    Kaur G; Nagpal D; Nagpal K
    Crit Rev Ther Drug Carrier Syst; 2020; 37(6):553-590. PubMed ID: 33426833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal and pediatric oral drug delivery: Hopes and hurdles.
    Mfoafo KA; Omidian M; Bertol CD; Omidi Y; Omidian H
    Int J Pharm; 2021 Mar; 597():120296. PubMed ID: 33524524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Formulations: Standards and Novel Strategies for Drug Administration in Pediatrics.
    Thabet Y; Klingmann V; Breitkreutz J
    J Clin Pharmacol; 2018 Oct; 58 Suppl 10():S26-S35. PubMed ID: 30248193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Oral Flexible Tablet (OFT) Formulation for Pediatric and Geriatric Patients: a Novel Age-Appropriate Formulation Platform.
    Chandrasekaran P; Kandasamy R
    AAPS PharmSciTech; 2017 Aug; 18(6):1972-1986. PubMed ID: 27921260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric Oral Formulations: An Updated Review of Commercially Available Pediatric Oral Formulations Since 2007.
    Strickley RG
    J Pharm Sci; 2019 Apr; 108(4):1335-1365. PubMed ID: 30447227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orally disintegrating tablets and orally disintegrating mini tablets - novel dosage forms for pediatric use.
    Comoglu T; Dilek Ozyilmaz E
    Pharm Dev Technol; 2019 Sep; 24(7):902-914. PubMed ID: 31215850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mini-tablets: a contemporary system for oral drug delivery in targeted patient groups.
    Aleksovski A; Dreu R; Gašperlin M; Planinšek O
    Expert Opin Drug Deliv; 2015 Jan; 12(1):65-84. PubMed ID: 25200881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral drug delivery in personalized medicine: unmet needs and novel approaches.
    Wening K; Breitkreutz J
    Int J Pharm; 2011 Feb; 404(1-2):1-9. PubMed ID: 21070842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric drug formulations: a review of challenges and progress.
    Ivanovska V; Rademaker CM; van Dijk L; Mantel-Teeuwisse AK
    Pediatrics; 2014 Aug; 134(2):361-72. PubMed ID: 25022739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Wish List for Drug Development in Pediatrics.
    Meyers R
    J Pharm Sci; 2020 Feb; 109(2):939-943. PubMed ID: 31676269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orally disintegrating films and mini-tablets-innovative dosage forms of choice for pediatric use.
    Preis M
    AAPS PharmSciTech; 2015 Apr; 16(2):234-41. PubMed ID: 25739913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerating Drug Development in Pediatric Oncology With the Clinical Pharmacology Storehouse.
    Shebley M; Menon RM; Gibbs JP; Dave N; Kim SY; Marroum PJ
    J Clin Pharmacol; 2019 May; 59(5):625-637. PubMed ID: 30562405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery devices for the administration of paediatric formulations: overview of current practice, challenges and recent developments.
    Walsh J; Bickmann D; Breitkreutz J; Chariot-Goulet M;
    Int J Pharm; 2011 Aug; 415(1-2):221-31. PubMed ID: 21640807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decoding the small size challenges of mini-tablets for enhanced dose flexibility and micro-dosing.
    Mitra B; Thool P; Meruva S; Aycinena JA; Li J; Patel J; Patel K; Agarwal A; Karki S; Bowen W
    Int J Pharm; 2020 Jan; 574():118905. PubMed ID: 31809860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gabapentin-saccharin co-crystals with enhanced physicochemical properties and
    Soliman II; Kandil SM; Abdou EM
    Pharm Dev Technol; 2020 Feb; 25(2):227-236. PubMed ID: 31671004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in pediatric drug use: A pharmacist point of view.
    Balan S; Hassali MA; Mak VSL
    Res Social Adm Pharm; 2017; 13(3):653-655. PubMed ID: 27493130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of mini-tablets as a flexible drug delivery tool.
    Mitra B; Chang J; Wu SJ; Wolfe CN; Ternik RL; Gunter TZ; Victor MC
    Int J Pharm; 2017 Jun; 525(1):149-159. PubMed ID: 28432019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 10 years EU regulation of pediatric medicines - impact on cardiovascular drug formulations.
    Thabet Y; Slavkova M; Breitkreutz J
    Expert Opin Drug Deliv; 2018 Mar; 15(3):261-270. PubMed ID: 29284286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric drug development: formulation considerations.
    Ali AA; Charoo NA; Abdallah DB
    Drug Dev Ind Pharm; 2014 Oct; 40(10):1283-99. PubMed ID: 24483293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation of medicines for children.
    Nunn T; Williams J
    Br J Clin Pharmacol; 2005 Jun; 59(6):674-6. PubMed ID: 15948931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.